Page last updated: 2024-10-22

am 251 and Psychotic Disorders

am 251 has been researched along with Psychotic Disorders in 2 studies

AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dahlén, A1
Zarei, M1
Melgoza, A1
Wagle, M1
Guo, S1
Zamberletti, E1
Viganò, D1
Guidali, C1
Rubino, T1
Parolaro, D1

Other Studies

2 other studies available for am 251 and Psychotic Disorders

ArticleYear
THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior.
    Scientific reports, 2021, 08-03, Volume: 11, Issue:1

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Dronabinol; N-Methylaspartate; Piperidines; Psych

2021
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:2

    Topics: Acute Disease; Animals; Antipsychotic Agents; Cannabinoids; Interpersonal Relations; Male; Piperidin

2012